Lorvotuzumab mertansine (ADC)
Lorvotuzumab mertansine is an ADC consisting of an NCAM-directed antibody and DM1, a potent derivative of maytansine, used for the study of several solid tumors and hematological tumors.
Product Specifications
Product Name Alternative
MGN901, huN901-DM1
Reactivity
Human
Applications
Research Grade Biosimilar
Stability
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks) . Store at -20°C 12 months. Store at -80°C long term.
Endotoxin
Please contact with the lab for this information.
Purity
>90% as determined by SEC.
Form
Liquid
Notes
For research use only. Not suitable for clinical or therapeutic use.
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
244558-ML405 100 µL
CDSN (corneodesmosin, D6S586E, HTSS, S) (MaxLight 405) discontinued
Ask
View Details 
132970-FITC 100 µL
SAR1A (GTP-binding Protein SAR1a, COPII-associated Small GTPase, Masra2, SAR1, SARA, SARA1) (FITC)
Ask
View Details